Annual Total Expenses
$25.71 M
-$31.89 M-55.37%
December 31, 2023
Summary
- As of February 7, 2025, LSTA annual total expenses is $25.71 million, with the most recent change of -$31.89 million (-55.37%) on December 31, 2023.
- During the last 3 years, LSTA annual total expenses has risen by +$6.56 million (+34.28%).
- LSTA annual total expenses is now -70.83% below its all-time high of $88.14 million, reached on December 1, 2010.
Performance
LSTA Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$5.34 M
-$187.00 K-3.39%
September 30, 2024
Summary
- As of February 7, 2025, LSTA quarterly total expenses is $5.34 million, with the most recent change of -$187.00 thousand (-3.39%) on September 30, 2024.
- Over the past year, LSTA quarterly total expenses has dropped by -$689.00 thousand (-11.44%).
- LSTA quarterly total expenses is now -85.85% below its all-time high of $37.72 million, reached on September 1, 2022.
Performance
LSTA Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
LSTA Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.4% | -11.4% |
| 3 y3 years | +34.3% | -11.4% |
| 5 y5 years | +51.3% | -11.4% |
LSTA Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.4% | at low | -85.8% | at low |
| 5 y | 5-year | -55.4% | +34.3% | -85.8% | +31.5% |
| alltime | all time | -70.8% | >+9999.0% | -85.8% | +3671.0% |
Lisata Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.34 M(-3.4%) |
| Jun 2024 | - | $5.52 M(-16.3%) |
| Mar 2024 | - | $6.60 M(+9.6%) |
| Dec 2023 | $25.71 M(-55.4%) | $6.03 M(+1.0%) |
| Sep 2023 | - | $5.96 M(-13.3%) |
| Jun 2023 | - | $6.88 M(+0.5%) |
| Mar 2023 | - | $6.84 M(+4.6%) |
| Dec 2022 | $57.60 M(+98.3%) | $6.54 M(-82.7%) |
| Sep 2022 | - | $37.72 M(+461.3%) |
| Jun 2022 | - | $6.72 M(+1.5%) |
| Mar 2022 | - | $6.62 M(-3.3%) |
| Dec 2021 | $29.05 M(+51.7%) | - |
| Dec 2021 | - | $6.85 M(-1.7%) |
| Sep 2021 | - | $6.97 M(-2.5%) |
| Jun 2021 | - | $7.15 M(-11.6%) |
| Mar 2021 | - | $8.09 M(+48.5%) |
| Dec 2020 | $19.14 M(-4.7%) | $5.45 M(+1.8%) |
| Sep 2020 | - | $5.35 M(+24.7%) |
| Jun 2020 | - | $4.29 M(+5.8%) |
| Mar 2020 | - | $4.06 M(-20.2%) |
| Dec 2019 | $20.09 M(+18.3%) | $5.08 M(+0.2%) |
| Sep 2019 | - | $5.07 M(-5.1%) |
| Jun 2019 | - | $5.35 M(+16.4%) |
| Mar 2019 | - | $4.59 M(+21.0%) |
| Dec 2018 | $16.99 M(-38.4%) | $3.80 M(+0.9%) |
| Sep 2018 | - | $3.76 M(-11.9%) |
| Jun 2018 | - | $4.27 M(-17.3%) |
| Mar 2018 | - | $5.16 M(-29.5%) |
| Dec 2017 | $27.59 M(-6.5%) | $7.32 M(+19.4%) |
| Sep 2017 | - | $6.13 M(-20.5%) |
| Jun 2017 | - | $7.71 M(+19.9%) |
| Mar 2017 | - | $6.43 M(+17.1%) |
| Dec 2016 | $29.50 M(-60.2%) | $5.49 M(-4.1%) |
| Sep 2016 | - | $5.73 M(-22.7%) |
| Jun 2016 | - | $7.41 M(-60.1%) |
| Mar 2016 | - | $18.56 M(+28.9%) |
| Dec 2015 | $74.06 M(-2.1%) | $14.40 M(-11.5%) |
| Sep 2015 | - | $16.27 M(-26.5%) |
| Jun 2015 | - | $22.14 M(+4.1%) |
| Mar 2015 | - | $21.26 M(+2.1%) |
| Dec 2014 | $75.68 M(+47.0%) | $20.83 M(+2.2%) |
| Sep 2014 | - | $20.38 M(+20.4%) |
| Jun 2014 | - | $16.92 M(-3.6%) |
| Mar 2014 | - | $17.55 M(+20.5%) |
| Dec 2013 | $51.48 M(+15.1%) | $14.57 M(+11.9%) |
| Sep 2013 | - | $13.02 M(+3.9%) |
| Jun 2013 | - | $12.53 M(+10.3%) |
| Mar 2013 | - | $11.36 M(+6.2%) |
| Dec 2012 | $44.72 M(+1.5%) | $10.69 M(-14.6%) |
| Sep 2012 | - | $12.52 M(+23.0%) |
| Jun 2012 | - | $10.18 M(-10.0%) |
| Mar 2012 | - | $11.32 M(-3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $44.05 M(-50.0%) | $11.77 M(+25.1%) |
| Sep 2011 | - | $9.41 M(-23.2%) |
| Jun 2011 | - | $12.25 M(-54.1%) |
| Mar 2011 | - | $26.67 M(+8.5%) |
| Dec 2010 | $88.14 M(+135.5%) | $24.57 M(+10.6%) |
| Sep 2010 | - | $22.22 M(-3.0%) |
| Jun 2010 | - | $22.91 M(+24.2%) |
| Mar 2010 | - | $18.44 M(-21.6%) |
| Dec 2009 | $37.43 M(+301.8%) | $23.53 M(+221.6%) |
| Sep 2009 | - | $7.32 M(+54.7%) |
| Jun 2009 | - | $4.73 M(+148.7%) |
| Mar 2009 | - | $1.90 M(-22.8%) |
| Dec 2008 | $9.32 M(-12.7%) | $2.46 M(+26.8%) |
| Sep 2008 | - | $1.94 M(-18.4%) |
| Jun 2008 | - | $2.38 M(-5.6%) |
| Mar 2008 | - | $2.52 M(+1.1%) |
| Dec 2007 | $10.67 M(+125.3%) | $2.50 M(-42.4%) |
| Sep 2007 | - | $4.33 M(+120.8%) |
| Jun 2007 | - | $1.96 M(+4.7%) |
| Mar 2007 | - | $1.87 M(+7.4%) |
| Dec 2006 | $4.74 M(+189.5%) | $1.74 M(+73.7%) |
| Sep 2006 | - | $1.00 M(-3.8%) |
| Jun 2006 | - | $1.04 M(+10.6%) |
| Mar 2006 | - | $943.70 K(+89.7%) |
| Dec 2005 | $1.64 M(+7.4%) | $497.50 K(-9.6%) |
| Sep 2005 | - | $550.40 K(+50.6%) |
| Jun 2005 | - | $365.40 K(+63.9%) |
| Mar 2005 | - | $222.90 K(-18.6%) |
| Dec 2004 | $1.52 M(+58.8%) | $273.70 K(-34.9%) |
| Sep 2004 | - | $420.40 K(0.0%) |
| Jun 2004 | - | $420.40 K(+2.9%) |
| Mar 2004 | - | $408.40 K(+6.4%) |
| Dec 2003 | $959.00 K(-22.1%) | $383.70 K(+80.9%) |
| Sep 2003 | - | $212.10 K(-4.3%) |
| Jun 2003 | - | $221.70 K(+56.7%) |
| Mar 2003 | - | $141.50 K(-62.3%) |
| Dec 2002 | $1.23 M(-28.2%) | $375.60 K(+53.4%) |
| Sep 2002 | - | $244.90 K(+11.7%) |
| Jun 2002 | - | $219.20 K(-43.9%) |
| Mar 2002 | - | $390.80 K(-20.5%) |
| Dec 2001 | $1.71 M(-32.6%) | $491.80 K(+17.5%) |
| Sep 2001 | - | $418.50 K(+12.0%) |
| Jun 2001 | - | $373.60 K(-4.1%) |
| Mar 2001 | - | $389.70 K(-44.2%) |
| Dec 2000 | $2.54 M(+148.7%) | $698.50 K(-32.2%) |
| Sep 2000 | - | $1.03 M(+99.0%) |
| Jun 2000 | - | $517.40 K(+91.2%) |
| Mar 2000 | - | $270.60 K |
| Dec 1999 | $1.02 M(+138.9%) | - |
| Dec 1998 | $428.20 K(+93.2%) | - |
| Mar 1998 | $221.60 K(-11.9%) | - |
| Mar 1997 | $251.60 K(-2.1%) | - |
| Mar 1996 | $257.10 K | - |
FAQ
- What is Lisata Therapeutics annual total expenses?
- What is the all time high annual total expenses for Lisata Therapeutics?
- What is Lisata Therapeutics annual total expenses year-on-year change?
- What is Lisata Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Lisata Therapeutics?
- What is Lisata Therapeutics quarterly total expenses year-on-year change?
What is Lisata Therapeutics annual total expenses?
The current annual total expenses of LSTA is $25.71 M
What is the all time high annual total expenses for Lisata Therapeutics?
Lisata Therapeutics all-time high annual total expenses is $88.14 M
What is Lisata Therapeutics annual total expenses year-on-year change?
Over the past year, LSTA annual total expenses has changed by -$31.89 M (-55.37%)
What is Lisata Therapeutics quarterly total expenses?
The current quarterly total expenses of LSTA is $5.34 M
What is the all time high quarterly total expenses for Lisata Therapeutics?
Lisata Therapeutics all-time high quarterly total expenses is $37.72 M
What is Lisata Therapeutics quarterly total expenses year-on-year change?
Over the past year, LSTA quarterly total expenses has changed by -$689.00 K (-11.44%)